TRxADE Health Inc (MEDS)

[Ed_Fran]

https://investors.trxadegroup.com/trxd-press-releases/

[sc00pnDump]

8kout

[Scumbag Fraudsters]

BULLSHIT

[dinogreeves]

MEDS had great news today. Should go higher next week, most probably in the teens by end of next week.

[Triple nickle]

Looking for 22.00 and higher

[Awl416]

15s blink of an eye

[Awl416]

Something leak?

[NiteShift]

Trader, you could be right buddy!!

Looks like insiders are slowly accumulating SBES!! Another 10 million traded so far today.

Hopefully we'll hear something soon!!!

$$$$SBES

[TRADER99]

Heard some rumours Suren will be rolling his former pharma business from here, MEDS, over to SBES later. We'll see

[Monksdream]

Wash trading

[SriMaharaj]

what is float? I believe it's less than 700K. Why is it traded 4.8M+ when float is only 700K?

[Monksdream]

MEDS resumed up another buck

[Monksdream]

MEDS halted

[Monksdream]

MEDS will be No 1 on the Barchart Top 100 when the normal market opens

[Monksdream]

Early Barchart Top 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc

[TRADER99]

This has been a great scalp play since r/s. Volatility...

[IOUBLOKE1]

Change of guards correct the situation.

[TheFinalCD]

THEN 12.80

THATS WHY I WAS BEARISH

JUST COULDNT SHORT IT

[IOUBLOKE1]

28 minutes later
21.85
14.85

[TheFinalCD]

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing



On June 23, 2023, the Listing Qualifications department of The Nasdaq Stock Market LLC (the “Nasdaq”) notified the Company that the Company was not in compliance with Nasdaq’s listing rules (the “Listing Rules”) as set forth in Listing Rule 5550(a)(4) given the Company’s failure to maintain a sufficient number of publicly held shares (the “Notice”). Citing the Company’s Event Form submitted to Nasdaq on June 7, 2023, Nasdaq calculated the Company’s publicly held shares as approximately 310,057 (which amount excludes shares held by officers, directors, or beneficial owners of 10 percent or more), on a post-split basis, effective as of June 22, 2023. To satisfy the requirement for continued listing on Nasdaq, the Company must maintain a minimum of 500,000 publicly held shares.

The Notice states that the Company has until August 7, 2023 to submit a plan to regain compliance with Listing Rule 5550(a)(4). If Nasdaq does not accept the Company’s plan, the Company will have the opportunity to appeal the decision in front of a Nasdaq Hearings Panel.

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year



On June 26, 2023, the Company filed a Certificate of Designation, Preferences, Rights and Limitations of the Series B Preferred Stock with the Secretary of State of the State of Delaware (the “Certificate of Designation”). The Certificate of Designation provides for the issuance of shares of the Company’s Series B Preferred Stock, par value $0.00001 per share (the “Series B Preferred Stock”).



Pursuant to the Certificate of Designation, the Series B Preferred Stock is non-participating and shall receive no dividends, has no liquidation preference, has no voting rights, and has no redemption rights.



The Series B Preferred Stock is not convertible at the election of the holder. Upon approval of conversion by the Company’s stockholders, each outstanding share of Series B Preferred Stock (including any fraction of a share) shall automatically convert into 100 shares of the Company’s common stock, par value $0.00001 per share, without any further action by the relevant holder of such Series B Preferred Stock or the Company.



In the event that a merger, acquisition of reorganization of the Company or its subsidiary with Superlatus, Inc., as previously disclosed in the Current Report on Form 8-K filed by the Company on June 23, 2023 does not close before December 31, 2023, the Company will repurchase all of the shares of Series B Preferred Stock for the price originally paid by each holder for the Series B Preferred Stock.



The foregoing description of the Certificate of Designation is a summary and is qualified in its entirety by the terms of the Certificate of Designation filed with the Secretary of State of the State of Delaware, which is attached hereto as Exhibit 3.1 and incorporated herein by reference.



Item 9.01. Financial Statements and Exhibits



Exhibit No. Description of Exhibit
3.1 Certificate of Designation of Series B Preferred Stock
104 Inline XBRL for the cover page of this Current Report on Form 8-K

[Triple nickle]

Nice

[Biggeoff]

Icahn or some dog is loading in $MEDS $20+ come Monday

[shankapotamus]

Look at it now. ??

[stock1ace1]

6.2 mill traded 600k float talk about manipulation

[PennyPusher786]

Float will be like 600k tomorrow?

[Triple nickle]

With some volume boom

[makinezmoney]

$MEDS: Tapping $0.60......... BOoommmmmmmmmmmmmmm


OHhhhhhhhhhhhhh yyyyaaaaaaaaaaaaaaaaaaaaaaaaa


NICe moves


GO $MEDS

[TheFinalCD]

https://finviz.com/quote.ashx?t=MEDS&ty=c&ta=1&p=d

[THEMASTERS_SON]

$1 should be a piece of…Cake

[THEMASTERS_SON]

,,,,,,, CHECKING IN

[DawgTrading]

$MEDS 0.38 to beat, then its off its chain!

[DawgTrading]

This is holding up well... might do well in after hours also... im going to hold this for a minute.

[makinezmoney]

$MEDS: She Taps 0.41 ........... MUahhhhhhhh ha ha hah ahaaaaaaaaaaaaa


https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170897273


Just another day on the markets, right ????




GO $MEDS

[makinezmoney]

$MEDS: Thanks for the props...............

I am on Twitter.............. but I'm mostly talking about $TMNA


Ya, hope you have a good year and rake it in.

There are some value plays out there no doubt........... watch TMPO rolling now


GO $MEDS

[pennyfinder]

Just wanted to give you a shout out. Your picks are spot on. One of the bests I’ve seen on ihub. You on twitter?

[DawgTrading]

Float is legit? This is a potential steal here at 0.34

Bought

[makinezmoney]

$MEDS: I noticed too........ added 20k at 0.33

Lets goooooooooooooooooooooooo


GO $MEDS

[photonspeeder]

$MEDS .42 5.5M float getting noticed

[$treet $inatra]

+26% ... easy 200% runner with any news

[$treet $inatra]

low 5.5M float at a mere .40

[$treet $inatra]

daily

[photonspeeder]

$MEDS great risk/reward at these levels

[$treet $inatra]

50ma @ $1.41 on the weekly https://schrts.co/YrfbsPyJ

[$treet $inatra]

looks to be bottoming out

[$treet $inatra]

scumbag crooks, bids deserve to be 0, best vote of no confidence!

[starkd748]

W pattern top at 1.50 down she goes poof...

[bandit007]

Nice power hour runner!! $MEDS

[TRADER99]

News: TAMPA, FL / ACCESSWIRE / September 20, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS)("TRxADE" or the "Company") an integrated drug procurement, delivery, and healthcare platform, today announced that Bonum Health, a Digital Healthcare business subsidiary, has signed a Telemedicine Services Distribution Deal with Wakefern Food Corp., to deploy telemedicine services throughout ShopRite pharmacy-led locations in New Jersey, New York, Pennsylvania, Connecticut, and Maryland.

Bonum Health will provide affordable telemedicine services and prescription discount savings to ShopRite customers by offering Bonum Health's signature Mobile Health Services application and prescriber program, staffed by over 650+ Board-Certified Medical Providers. The service, which allows customers to connect virtually with doctors and healthcare providers, to get the care they need, also provides access to prescription discount savings through the innovative Bonum Health telemedicine application, which can be downloaded from both Google Play and Apple App stores.

Dr. Shafaat Pirani, PharmD, BCGP, Chief Clinical and Compliance Officer for TRxADE states, "We are ecstatic about working strategically with Wakefern Food Corp., the retailer-owned supermarket cooperative, to offer deep discounts for telemedicine services in the tristate area and neighboring states. The relationship speaks to the ethos of what Bonum Health is all about - improving access to healthcare services for the growing uninsured and under-insured population. Today, it is more important than ever to make sure people have affordable and accessible healthcare."

"This partnership will highlight synergies across both brands, such as a preferred Veterinary plan where customers will be able to access Tele-Veterinary services in select markets and receive their pet prescriptions and over-the-counter drugs. These are precisely the value-based opportunities we believe customers are looking for today," Dr. Pirani added.

"Telemedicine provides a convenient and user-friendly way for people to access health care services. With providers and patients looking to break down physical and scheduling barriers to delivering and receiving care, telehealth offers a seamless, accessible health care solution. We are excited to introduce Bonum Health's signature Mobile Health Services application to help our customers achieve their health and wellness goals," said Joe Montoto, RPh, Pharmacy Business Development Manager at Wakefern Food Corp.

"We are pleased to announce this collaboration with Wakefern Food Corp and Bonum Health, as it demonstrates our commitment to expanding our affordable and convenient telemedicine services with our supermarket partners. We look forward to building on this opportunity and creating innovative, game-changing health care solutions," said Suren Ajjarapu, Chairman and Chief Executive Officer of TRxADE.

[TRADER99]

Odd volume here. Suren is also an officer of $BES. Wondering if something is cooking inside the pot between them...

[MT101]

Loading these dips. Seems like the MMs keep setting a fake wall then it booms